Dr Li’s team concluded that “patients with SLE-TMA exhibit a progressive decline of patient and renal survival in the long-term. Prompt diagnosis and risk stratification based on identified risk ...

Long-term control of cardiovascular risk factors and sustained clinical remission help to mitigate the higher risk for ...

Pregnant women with systemic lupus erythematosus (SLE) who experience cardiovascular events are at high risk for adverse outcomes.

Even years later, patients whose symptoms were initially dismissed experience distrust and uncertainty with clinicians.

Three years of remission from lupus nephritis appears to be the minimum period of time that protects against impaired kidney ...

Procalcitonin levels greater than 0.9 ng/mL may be a useful biomarker for identifying bacterial infections among febrile patients with JSLE.

This mysterious autoimmune disease presents with over 100 different symptoms, making diagnosis incredibly challenging for ...

Lupus is a rare autoimmune disease characterized by chronic inflammation. It presents in four main forms: systemic lupus ...

Margrit Wiesendanger, MD, PhD, highlights how social determinants of health and equitable treatment access are critical to improving lupus outcomes, particularly in minority populations.

Autoimmune disease symptoms vary greatly depending on which part of the body is affected, but some common symptoms include ...

A new study will evaluate the safety and efficacy of universal allogeneic anti-CD19/BCMA CAR T-cells in relapsed or refractory autoimmune diseases including antineutrophil cytoplasmic antibody ...

The US Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) designation to AbelZeta ...